Literature DB >> 16212400

Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues.

Roberto A Perego1, Cristina Bianchi, Matteo Corizzato, Barbara Eroini, Barbara Torsello, Cristina Valsecchi, Andrea Di Fonzo, Nicoletta Cordani, Paolo Favini, Stefano Ferrero, Marina Pitto, Cecilia Sarto, Fulvio Magni, Francesco Rocco, Paolo Mocarelli.   

Abstract

Renal cell carcinoma (RCC) tissue is composed of a mixture of neoplastic and normal cells, which complicate proteome analysis. The aim of our study was to investigate whether it is feasible to establish primary cell cultures of RCC and of renal cortex maintaining the tissue phenotype along with a more homogeneous and enriched cytological material. Fourteen (82.3%) primary cultures from 17 surgical cases were established and characterized by morphology, growth rate, immunocytochemistry, and molecular analysis performed by Real-time PCR, Western blotting, two-dimensional electrophoresis (2-DE), and mass spectrometry. Cultures showed >90% cytokeratine-positive epithelial cells. In primary tumor cultures, the molecular phenotype of manganese superoxide dismutase and heat shock protein 27 was the same as that found in tumor tissues with overexpression and increased number of isoforms. Moreover, 27 out 28 specific proteins and their isoforms, present in spots excised from 2-DE gel of cortex or RCC cultures, corresponded to those identified on the 2-DE tissue cortex reference map, suggesting that these primary cultures retain the proteomic profile of the corresponding tissues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212400     DOI: 10.1021/pr050002o

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  12 in total

1.  Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.

Authors:  Cristina Bianchi; Silvia Bombelli; Francesca Raimondo; Barbara Torsello; Valentina Angeloni; Stefano Ferrero; Vitalba Di Stefano; Clizia Chinello; Ingrid Cifola; Lara Invernizzi; Paolo Brambilla; Fulvio Magni; Marina Pitto; Gianpaolo Zanetti; Paolo Mocarelli; Roberto A Perego
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

2.  Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.

Authors:  Barbara Seliger; Sven P Dressler; Ena Wang; Roland Kellner; Christian V Recktenwald; Friedrich Lottspeich; Francesco M Marincola; Maja Baumgärtner; Derek Atkins; Rudolf Lichtenfels
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

Review 3.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

4.  Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues.

Authors:  Ingrid Cifola; Cristina Bianchi; Eleonora Mangano; Silvia Bombelli; Fabio Frascati; Ester Fasoli; Stefano Ferrero; Vitalba Di Stefano; Maria A Zipeto; Fulvio Magni; Stefano Signorini; Cristina Battaglia; Roberto A Perego
Journal:  BMC Cancer       Date:  2011-06-13       Impact factor: 4.430

5.  Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma.

Authors:  Nicole M A White; Olena Masui; Leroi V Desouza; Olga Krakovska; Shereen Metias; Alexander D Romaschin; R John Honey; Robert Stewart; Kenneth Pace; Jason Lee; Michael As Jewett; Georg A Bjarnason; K W Michael Siu; George M Yousef
Journal:  Oncotarget       Date:  2014-01-30

6.  Establishment and characterization of a highly immunogenic human renal carcinoma cell line.

Authors:  Clelia Prattichizzo; Margherita Gigante; Paola Pontrelli; Alessandro Stella; Maria Teresa Rocchetti; Maddalena Gigante; Eugenio Maiorano; Wolfgang Herr; Michele Battaglia; Loreto Gesualdo; Elena Ranieri
Journal:  Int J Oncol       Date:  2016-05-27       Impact factor: 5.650

7.  Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma.

Authors:  Haiping Tang; Yuling Chen; Xiaohui Liu; Shiyu Wang; Yang Lv; Di Wu; Qingtao Wang; Minkui Luo; Haiteng Deng
Journal:  Oncotarget       Date:  2016-06-21

Review 8.  From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.

Authors:  Androu Arsanious; Georg A Bjarnason; George M Yousef
Journal:  Mol Cancer       Date:  2009-03-17       Impact factor: 27.401

9.  Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma.

Authors:  Zejun Lu; Yuqin Yao; Qi Song; Jinliang Yang; Xiangfei Zhao; Ping Yang; Jingbo Kang
Journal:  Onco Targets Ther       Date:  2016-03-09       Impact factor: 4.147

10.  The glucose and lipid metabolism reprogramming is grade-dependent in clear cell renal cell carcinoma primary cultures and is targetable to modulate cell viability and proliferation.

Authors:  Cristina Bianchi; Chiara Meregalli; Silvia Bombelli; Vitalba Di Stefano; Francesco Salerno; Barbara Torsello; Sofia De Marco; Giorgio Bovo; Ingrid Cifola; Eleonora Mangano; Cristina Battaglia; Guido Strada; Giuseppe Lucarelli; Robert H Weiss; Roberto A Perego
Journal:  Oncotarget       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.